Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.
作者信息
Seccia Teresa M, Caroccia Brasilina, Adler Gail K, Maiolino Giuseppe, Cesari Maurizio, Rossi Gian Paolo
机构信息
From the Clinica dell'Ipertensione Arteriosa, Department of Medicine-DIMED, University of Padua, Italy (T.M.S., B.C., G.M., M.C., G.P.R.); and Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (G.K.A.).
出版信息
Hypertension. 2017 Apr;69(4):545-550. doi: 10.1161/HYPERTENSIONAHA.116.08956.
Abstract
摘要
相似文献
1
Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.
Hypertension. 2017 Apr;69(4):545-550. doi: 10.1161/HYPERTENSIONAHA.116.08956.
2
Arterial Hypertension, Aldosterone, and Atrial Fibrillation.
Curr Hypertens Rep. 2019 Nov 18;21(12):94. doi: 10.1007/s11906-019-1001-4.
3
Conn's syndrome and atrial fibrillation.
Lancet. 2001 Apr 21;357(9264):1293-4. doi: 10.1016/S0140-6736(00)04439-1.
4
Low-renin hypertension with hyperaldosteronism in childhood.
Prog Biochem Pharmacol. 1980;17:54-7.
5
Atrial Fibrillation and Hypertension.
Hypertension. 2017 Nov;70(5):854-861. doi: 10.1161/HYPERTENSIONAHA.117.08934. Epub 2017 Sep 11.
6
Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis.
J Hypertens. 2013 Jan;31(1):214-5. doi: 10.1097/HJH.0b013e32835ae9a3.
7
Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis.
J Hypertens. 2013 Jan;31(1):215-6. doi: 10.1097/HJH.0b013e32835ae9b3.
8
Effects of atrial fibrillation on arterial stiffness in patients with hypertension.
Angiology. 2008 Aug-Sep;59(4):459-63. doi: 10.1177/0003319707309305. Epub 2008 Apr 2.
9
The challenge of renal cystic disease and its association with hypertension, age and abnormal potassium handling.
J Hypertens. 2007 Jul;25(7):1347-9. doi: 10.1097/HJH.0b013e32814db544.
10
Hypertension, stroke and the impact of atrial fibrillation.
Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1287-9. doi: 10.1586/14779072.6.10.1287.
引用本文的文献
1
Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: an umbrella review.
Int J Surg. 2024 Nov 1;110(11):7367-7380. doi: 10.1097/JS9.0000000000002048.
2
Aldosterone Effect on Cardiac Structure and Function.
Curr Cardiol Rev. 2024;20(4):e290224227534. doi: 10.2174/011573403X281390240219063817.
3
Comparative effect of antihypertensive drugs in improving arterial stiffness in adults with hypertension (RIGIPREV study). A network meta-analysis.
Front Pharmacol. 2023 Sep 1;14:1225795. doi: 10.3389/fphar.2023.1225795. eCollection 2023.
4
Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes.
Front Endocrinol (Lausanne). 2023 May 26;14:1147225. doi: 10.3389/fendo.2023.1147225. eCollection 2023.
5
A New Lignan from L. (Annonaceae) Demonstrates Vasorelaxant Effects In Vitro.
Molecules. 2023 May 23;28(11):4256. doi: 10.3390/molecules28114256.
6
Transcriptomic profile analysis of the left atrium in spontaneously hypertensive rats in the early stage.
Front Pharmacol. 2022 Oct 17;13:989636. doi: 10.3389/fphar.2022.989636. eCollection 2022.
7
Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.
J Hum Hypertens. 2023 Sep;37(9):757-766. doi: 10.1038/s41371-022-00753-2. Epub 2022 Sep 24.
8
Stroke Risks in Primary Aldosteronism with Different Treatments: A Systematic Review and Meta-Analysis.
J Cardiovasc Dev Dis. 2022 Sep 8;9(9):300. doi: 10.3390/jcdd9090300.
9
Genetic inhibition of serum glucocorticoid kinase 1 prevents obesity-related atrial fibrillation.
JCI Insight. 2022 Oct 10;7(19):e160885. doi: 10.1172/jci.insight.160885.
10
Treatment of Primary Aldosteronism and Reversal of Renin Suppression Improves Left Ventricular Systolic Function.
Front Endocrinol (Lausanne). 2022 Jun 30;13:916744. doi: 10.3389/fendo.2022.916744. eCollection 2022.
本文引用的文献
1
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
2
Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study.
Circ Cardiovasc Imaging. 2016 Jun;9(6). doi: 10.1161/CIRCIMAGING.116.004815.
3
Cardiac Tissue Injury and Remodeling Is Dependent Upon MR Regulation of Activation Pathways in Cardiac Tissue Macrophages.
Endocrinology. 2016 Aug;157(8):3213-23. doi: 10.1210/en.2016-1040. Epub 2016 Jun 2.
4
Atrial fibrillation and arterial hypertension: A common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role.
Int J Cardiol. 2016 Mar 1;206:71-6. doi: 10.1016/j.ijcard.2016.01.007. Epub 2016 Jan 6.
5
Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.
Hypertension. 2015 Aug;66(2):368-73. doi: 10.1161/HYPERTENSIONAHA.115.05728. Epub 2015 Jun 8.
6
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.
Lancet. 2015 Jul 11;386(9989):154-62. doi: 10.1016/S0140-6736(14)61774-8. Epub 2015 May 7.
7
Getting to the heart of the matter: new insights into cardiac fibrosis.
Circ Res. 2015 Mar 27;116(7):1269-76. doi: 10.1161/CIRCRESAHA.116.305381.
8
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.
Circulation. 2015 Jan 6;131(1):34-42. doi: 10.1161/CIRCULATIONAHA.114.013255. Epub 2014 Nov 18.
9
Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.
Circ Res. 2014 Apr 25;114(9):1483-99. doi: 10.1161/CIRCRESAHA.114.302226.
10
The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.
J Biol Chem. 2014 Mar 7;289(10):6656-6668. doi: 10.1074/jbc.M113.519256. Epub 2014 Jan 27.
Zotero 插件